DSpace at RU >

Browsing by Author Cats, A.

Full Text	Issue Date	Title	Author(s)
	2011	Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer	Deenen, M.J.; Tol, J.; Burylo, A.M.; Doodeman, V.D.; Boer, A. de, et al
	2011	[Familial gastric cancer: diagnosis, treatment and periodic surveillance]	Kluijt, I.; Sijmons, R.H.; Hoogerbrugge, N.; Vasen, H.F.; Cats, A.
	2011	The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.	Bokkerink, G.M.; Graaf, E.J. de; Punt, C.J.; Nagtegaal, I.D.; Rütten, H., et al
	2010	Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study.	Boparai, K.S.; Mathus-Vliegen, E.M.H.; Koornstra, J.J.; Nagengast, F.M.; Leerdam, M. van, et al
	2010	Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.	Tol, J.; Koopman, M.; Miller, M.C.; Tibbe, A.; Cats, A., et al
	2010	One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.	Vasen, H.F.; Abdirahman, M.; Brohet, R.; Langers, A.M.; Kleibeuker, J.H., et al
	2010	Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.	Lammens, C.R.; Bleiker, E.M.A.; Aaronson, N.K.; Wagner, A.; Sijmons, R.H., et al
	2009	Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.	Tol, J.; Koopman, M.; Cats, A.; Rodenburg, C.J.; Creemers, G.J., et al
	2009	Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.	Vrieling, A.; Voskuil, D.W.; Bosma, A.; Majoor, D.M.; Doorn, J. van, et al
	2008	A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.	Tol, J.; Koopman, M.; Rodenburg, C.J.; Cats, A.; Creemers, G.J., et al
	2008	No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.	Vrieling, A.; Rookus, M.A.; Kampman, E.; Bonfrer, J.M.G.; Bosma, A., et al
	2008	Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation.	Tol, J.; Cats, A.; Mol, L.; Koopman, M.; Bos, M.M., et al
	2007	Is surveillance of the small bowel indicated for Lynch syndrome families?	Kate, G.L. ten; Kleibeuker, J.H.; Nagengast, F.M.; Craanen, M.; Cats, A., et al
	2007	Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.	Vrieling, A.; Rookus, M.A.; Kampman, E.; Bonfrer, J.M.G.; Korse, C.M., et al
	2007	Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.	Vrieling, A.; Voskuil, D.W.; Bonfrer, J.M.G.; Korse, C.M.; Doorn, J. van, et al
	2007	Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.	Hospers, G.; Punt, C.J.A.; Tesselaar, M.E.; Cats, A.; Havenga, K., et al
	2006	What is the appropriate screening protocol in Lynch syndrome?	Jong, A.E. de; Nagengast, F.M.; Kleibeuker, J.H.; Meeberg, P.C. van de; Wijk, H.J. van, et al
	2006	Decrease in mortality in Lynch syndrome families because of surveillance.	Jong, A.E. de; Hendriks, Y.M.; Kleibeuker, J.H.; Boer, S.Y. de; Cats, A., et al
	2005	Prevalence of adenomas among young individuals at average risk for colorectal cancer.	Jong, A.E. de; Morreau, H.; Nagengast, F.M.; Mathus-Vliegen, E.M.H.; Kleibeuker, J.H., et al
	2004	The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.	Jong, A.E. de; Morreau, H.; Puijenbroek, M.; Eilers, P.H.; Wijnen, J.T., et al
	2004	Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.	Vos tot Nederveen Cappel, W.H. de; Meulenbeld, H.J.; Kleibeuker, J.H.; Nagengast, F.M.; Menko, F.H., et al
	2003	Begeleiding kankerpatienten bij een existentiele crisis	Yang, W.; Staps, T.; Hijmans, E.J.S.; Cats, A.
	2003	Kanker: eindigheid, zin en spiritualiteit : een samenwerkingsproject	Staps, T.; Yang, W.; Hijmans, E.J.S.; Cats, A.
	1987	Factors influencing the incidence of infections in Felty's syndrome	Breedveld, F.C.; Fibbe, W.E.; Hermans, J.; Meer, J.W.M. van der; Cats, A.